AYTU — AYTU BIOPHARMA INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About AYTU BIOPHARMA INC (AYTU)
AYTU BIOPHARMA INC (AYTU) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $100,576. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in AYTU
How many top investors track AYTU
Only 1 tracked investor report this position.
AYTU Ownership Composition
How AYTU BIOPHARMA INC is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting AYTU
- Ken GriffinMar 31, 2026Citadel AdvisorsShares36.8KValue$100.6K% Portfolio0.00%
Recent activity
- New$100.6KMay 15, 2026
Frequently asked questions
- How many institutional investors hold AYTU?
- 1 tracked institutional investor disclosed a position in AYTU (AYTU BIOPHARMA INC) in their most recent 13F filing.
- Who is the largest institutional holder of AYTU?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in AYTU, valued at $100,576.
- Did institutional ownership of AYTU increase or decrease?
- Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited AYTU.
- Where does this AYTU ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.